Berna Dogan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Berna Dogan has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Arif Aslaner
Department of General Surgery, Antalya Education and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey
1 shared publication - Berkay Turkmen
Department of Ophthalmology, Antalya Education and Research Hospital, University of Health Sciences, Antalya, Turkey
1 shared publication Birumut Gedik
Department of Ophthalmology, Antalya Education and Research Hospital, University of Health Sciences, Antalya, Turkey
1 shared publication- Birumut Gedik
Department of Ophthalmology, Antalya Serik State Hospital, Antalya, Turkey
1 shared publication - Elcin Suren
Department of Ophthalmology, Antalya Training and Research Hospital, Antalya, Turkey
1 shared publication - Ersan Cetinkaya
Department of Ophthalmology, Antalya Training and Research Hospital, University of Health Sciences, Antalya, Turkey
1 shared publication
Latest Publications
- 4 October 2023
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 44, 103826
Optical coherence tomography angiography evaluation of optic disc and retinal vascular densities in obese patients
- 4 October 2023
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 44, 103826
Optical coherence tomography angiography evaluation of optic disc and retinal vascular densities in obese patients
- Open Access
- 1 January 2023
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 86 (5) , 1-7
Ocular surface assessment and morphological alterations in meibomian glands with non-contact meibography in electronic cigarette smokers
Purpose: The study aimed to evaluate the ocular surface and meibomian gland morphology in electronic cigarette (e-cigarette) smokers. Methods: The upper and lower eyelids of 25 male e-cigarette smokers and 25 healthy male non-smoker patients were evaluated using Sirius meibography. Meibomian glands loss was automatically calculated using Phoenix meibography imaging software module, with the result obtained as percentage loss. Ocular Surface Disease Index (OSDI) questionnaire, tear breakup time test, and Schirmer II test were administered and performed in all cases. Results: The mean e-cigarette smoking duration was 4.9 ± 0.9 (range, 3.4-7) years. While the mean Schirmer II test value was 9.16 ± 2.09 mm in e-cigarette group, it was 11.20 ± 2.14 mm in control group (p=0.003). Mean tear breakup time was 6.96 ± 2.31 seconds in e-cigarette group and 9.84 ± 2.13 seconds in control group (p=0.002). The mean OSDI value was 28.60 ± 6.54 and 15.16 ± 7.23 in e-cigarette and control groups, respectively (p<0.001). In Sirius meibography, the average loss for the upper eyelid was 23.08% ± 6.55% in e-cigarette group and 17.60% ± 4.94% in control group (p=0.002), and the average loss for the lower eyelid was 27.84% ± 5.98% and 18.44% ± 5.91%, respectively (p<0.001). Additionally, a significant positive correlation was identified between the loss rates for both upper and lower eyelid meibography with e-cigarette smoking duration (r=0.348, p<0.013 and r=0.550, p<0.001, respectively). Conclusion: Long-term e-cigarette smoking causes damage to the meibomian glands; therefore, meibomian gland damage should be considered in ocular surface disorders due to e-cigarette smoking.
- 1 January 2023
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 86 (5) , 1-7
Open AccessOcular surface assessment and morphological alterations in meibomian glands with non-contact meibography in electronic cigarette smokers
Purpose: The study aimed to evaluate the ocular surface and meibomian gland morphology in electronic cigarette (e-cigarette) smokers. Methods: The upper and lower eyelids of 25 male e-cigarette smokers and 25 healthy male non-smoker patients were evaluated using Sirius meibography. Meibomian glands loss was automatically calculated using Phoenix meibography imaging software module, with the result obtained as percentage loss. Ocular Surface Disease Index (OSDI) questionnaire, tear breakup time test, and Schirmer II test were administered and performed in all cases. Results: The mean e-cigarette smoking duration was 4.9 ± 0.9 (range, 3.4-7) years. While the mean Schirmer II test value was 9.16 ± 2.09 mm in e-cigarette group, it was 11.20 ± 2.14 mm in control group (p=0.003). Mean tear breakup time was 6.96 ± 2.31 seconds in e-cigarette group and 9.84 ± 2.13 seconds in control group (p=0.002). The mean OSDI value was 28.60 ± 6.54 and 15.16 ± 7.23 in e-cigarette and control groups, respectively (p<0.001). In Sirius meibography, the average loss for the upper eyelid was 23.08% ± 6.55% in e-cigarette group and 17.60% ± 4.94% in control group (p=0.002), and the average loss for the lower eyelid was 27.84% ± 5.98% and 18.44% ± 5.91%, respectively (p<0.001). Additionally, a significant positive correlation was identified between the loss rates for both upper and lower eyelid meibography with e-cigarette smoking duration (r=0.348, p<0.013 and r=0.550, p<0.001, respectively). Conclusion: Long-term e-cigarette smoking causes damage to the meibomian glands; therefore, meibomian gland damage should be considered in ocular surface disorders due to e-cigarette smoking.
- 30 November 2022
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 41, 103218
Optic disc and retinal vessel densities assessment by optical coherence tomography angiography in patients with keratoconus
- 30 November 2022
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 41, 103218
Optic disc and retinal vessel densities assessment by optical coherence tomography angiography in patients with keratoconus